Showing results (1-10 of 67) with videos related to
Sort By:
Pageof 7
International Journal of Clinical and Experimental Medicine|January 16, 2016
Laparoscopic versus open hepatectomy for hepatocellular carcinoma: short- and long-term outcomes comparisonLanyun Luo, Haibo Zou, Yutong Yao, et al.Clinical Pharmacology in Drug Development|January 16, 2023
Pharmacokinetic and Bioequivalence Studies of 2 Metformin Glibenclamide Tablets in Healthy Chinese Subjects Under Fasting and Fed ConditionsXiaolun Huang, Jiao Huang, Xinjing Li, et al.Journal of Cancer Research and Clinical Oncology|August 30, 2023
The ALKBH5/SOX4 axis promotes liver cancer stem cell properties via activating the SHH signaling pathwayQinyan Yang, Yuxin Liang, Ying Shi, et al.Frontiers in Endocrinology|December 16, 2020
Repression of <i>MicroRNA-124-3p</i> Alleviates High-Fat Diet-Induced Hepatosteatosis by Targeting Pref-1Guan Wang, Haibo Zou, Chunyou Lai, et al.Oncology Letters|May 8, 2026
Neoadjuvant radiotherapy for resectable hepatocellular carcinoma with vascular invasion: A systematic review and meta-analysisYuhao Su, Yuxin Liang, Deyuan Zhong, et al.Journal of Hepatocellular Carcinoma|June 22, 2026
Tumor-Associated Macrophages in Hepatocellular Carcinoma: From Ontogeny and Heterogeneity to Immune Evasion and Therapeutic TargetingYuhao Su, Yuxin Liang, Deyuan Zhong, et al.Experimental Cell Research|April 15, 2014
Influence of interferon-α on the expression of the cancer stem cell markers in pancreatic carcinoma cellsYifan Zhu, Svetlana Karakhanova, Xiaolun Huang, et al.Technology in Cancer Research & Treatment|February 5, 2026
Prognostic Value of the Ratio of Interleukin-2 and Interleukin-10 in Patients with Hepatocellular Carcinoma Treated with Anti-PD-1 TherapyDeyuan Zhong, Yuxin Liang, Yuhao Su, et al.Journal of Gastroenterology|March 5, 2021
Emerging role and therapeutic application of exosome in hepatitis virus infection and associated diseasesYing Shi, Lingyao Du, Duoduo Lv, et al.Frontiers in Immunology|December 12, 2025
Preoperative TACE with PD-1 inhibitors and TKIs in beyond "up-to-seven" hepatocellular carcinoma: a propensity score matched analysisDeyuan Zhong, Yuxin Liang, YaHui Chen, et al.Pageof 7